---
title: "本周全球重要新闻：葛兰素史克、三星电子和汇丰控股等知名公司位列其中"
description: "美国股指上涨，受到主要银行强劲财报的提振。标准普尔 500 指数和纳斯达克分别上涨 0.2% 和 0.6%，而道琼斯指数下跌 0.2%。在欧洲，股市下跌 0.7%，因为欧洲央行维持利率不变。葛兰素史克和汇丰控股报告了积极的财报，而斯特兰蒂斯则面临指控。在亚洲，结果喜忧参半，三星在内存芯片方面创下了收入纪录，而比亚迪的利润下降了 33%。日本银行维持利率不变，暗示未来的加息将取决于经济状况"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/263906494.md"
published_at: "2025-11-02T17:30:10.000Z"
---

# 本周全球重要新闻：葛兰素史克、三星电子和汇丰控股等知名公司位列其中

> 美国股指上涨，受到主要银行强劲财报的提振。标准普尔 500 指数和纳斯达克分别上涨 0.2% 和 0.6%，而道琼斯指数下跌 0.2%。在欧洲，股市下跌 0.7%，因为欧洲央行维持利率不变。葛兰素史克和汇丰控股报告了积极的财报，而斯特兰蒂斯则面临指控。在亚洲，结果喜忧参半，三星在内存芯片方面创下了收入纪录，而比亚迪的利润下降了 33%。日本银行维持利率不变，暗示未来的加息将取决于经济状况

US stock indexes ended the week higher, supported by encouraging earnings reports from major U.S. banks. Out of the 173 S&P 500 companies that reported earnings this week, 142 of them beat EPS estimates, while 127 of those names surpassed revenue expectations. Meanwhile, the Federal Reserve cut interest rates by a quarter point in October 2025, al...

### Related Stocks

- [SSNGY.US - 三星电子](https://longbridge.com/zh-CN/quote/SSNGY.US.md)
- [HSBC.US - 汇丰](https://longbridge.com/zh-CN/quote/HSBC.US.md)
- [00005.HK - 汇丰控股](https://longbridge.com/zh-CN/quote/00005.HK.md)
- [GSK.UK - 葛兰素史克](https://longbridge.com/zh-CN/quote/GSK.UK.md)
- [GSK.US - 葛兰素史克](https://longbridge.com/zh-CN/quote/GSK.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| GSK Recieves Approval For Exdensur From The European Commission | GSK plc :GSK PLC - EXDENSUR APPROVED BY THE EUROPEAN COMMISSIONGSK PLC - EXDENSUR APPROVED BY THE EUROPEAN COMMISSION | [Link](https://longbridge.com/zh-CN/news/276102835.md) |
| GSK Begins Up to GBP450 Million Share Buyback Tranche | GSK Begins Up to GBP450 Million Share Buyback Tranche | [Link](https://longbridge.com/zh-CN/news/276103252.md) |
| Berenberg Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK) | Berenberg Bank analyst Kerry Holford has maintained a Hold rating on GlaxoSmithKline (GSK) with a price target of £20.00 | [Link](https://longbridge.com/zh-CN/news/276103203.md) |
| GSK Begins Fourth Tranche Of Up To GBP 0.45 Bln Share Buyback Under GBP 2 Bln Programme | British drug major GSK plc has announced the commencement of the fourth tranche of its £2 billion share buyback program, | [Link](https://longbridge.com/zh-CN/news/276103384.md) |
| Exdensur approved in EU for severe asthma and CRSwNP | GSK has received European Commission approval for Exdensur (depemokimab), the first ultra-long-acting biologic for sever | [Link](https://longbridge.com/zh-CN/news/276226507.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。